- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
EXHIBIT 21.1
SUBSIDIARIES OF GYRE THERAPEUTICS, INC.
Note: Gyre Therapeutics, Inc. or one of its Subsidiaries has 100% ownership of the Subsidiaries listed below, except for Beijing Continent Pharmaceuticals Co., Ltd. (65.2%) and Beijing Continent Biomedical Technology Co., Ltd (65.2%).
Subsidiaries | Jurisdiction |
Further Challenger International Limited | British Virgin Islands |
Nepenthe Holdings Limited | Hong Kong |
Ratel Holdings Limited | British Virgin Islands |
Aaring Limited | Hong Kong |
Rosefinch Holdings Limited | British Virgin Islands |
Continent Pharmaceuticals Inc. | Cayman Islands |
BJContinent Pharmaceuticals Limited | Hong Kong |
Beijing Continent Pharmaceuticals Co., Ltd. | People’s Republic of China |
Beijing Continent Biomedical Technology Co., Ltd. | People’s Republic of China |